Cargando…

Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ

BACKGROUND: Ipsilateral breast tumor recurrence (IBTR) after partial breast resection and contralateral breast tumor recurrence (CBTR) have been shown to occur relatively frequently in patients with ductal carcinoma in situ (DCIS). However, there is only limited data from Japanese institutes to supp...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamura, Nobuko, Tsuda, Hitoshi, Yoshida, Masayuki, Hojo, Takashi, Akashi-Tanaka, Sadako, Kinoshita, Takayuki, Sugihara, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839035/
https://www.ncbi.nlm.nih.gov/pubmed/25666939
http://dx.doi.org/10.1007/s12282-015-0595-x
_version_ 1782428076820398080
author Tamura, Nobuko
Tsuda, Hitoshi
Yoshida, Masayuki
Hojo, Takashi
Akashi-Tanaka, Sadako
Kinoshita, Takayuki
Sugihara, Kenichi
author_facet Tamura, Nobuko
Tsuda, Hitoshi
Yoshida, Masayuki
Hojo, Takashi
Akashi-Tanaka, Sadako
Kinoshita, Takayuki
Sugihara, Kenichi
author_sort Tamura, Nobuko
collection PubMed
description BACKGROUND: Ipsilateral breast tumor recurrence (IBTR) after partial breast resection and contralateral breast tumor recurrence (CBTR) have been shown to occur relatively frequently in patients with ductal carcinoma in situ (DCIS). However, there is only limited data from Japanese institutes to support this. METHODS: Of 301 consecutive DCIS patients, 179 patients underwent a mastectomy, and the other 122 underwent partial resection in the National Cancer Center Hospital, Tokyo, with a median follow-up period of 2,106 days. We reviewed clinicopathological parameters including age, menopausal status, body mass index, family history (FH) of breast cancer, tumor size, histological subtype, nuclear grade (NG), hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) status, treatment, and the surgical margin status of partially resected specimens. The risk associated with each of these parameters for IBTR in 122 patients who underwent partial resections, and for CBTR in a total of 301 patients were calculated using Cox proportional hazard general linear models. RESULTS: Of the 122 patients who underwent partial breast resection, IBTR occurred in 7 (5.7 %). The risk of IBTR was higher or tended to be higher in younger patients or those with lower NG tumors, but did not change significantly with respect to margin status or irradiation. Amongst the entire cohort of 301 patients, CBTR occurred in 18 cases (6.0 %). CBTR occurred significantly more frequently in patients with a FH of breast cancer and with HR+/HER2− subtype tumors by univariate analyses, and tumor subtype was an independent risk factor for CBTR by multivariate analysis. CONCLUSIONS: The local recurrence rate was low following partial resection of DCIS. Younger age was a risk factor for IBTR, whereas the HR+/HER2− tumor subtype and a FH of breast cancer were risk factors for CBTR.
format Online
Article
Text
id pubmed-4839035
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Japan
record_format MEDLINE/PubMed
spelling pubmed-48390352016-05-11 Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ Tamura, Nobuko Tsuda, Hitoshi Yoshida, Masayuki Hojo, Takashi Akashi-Tanaka, Sadako Kinoshita, Takayuki Sugihara, Kenichi Breast Cancer Original Article BACKGROUND: Ipsilateral breast tumor recurrence (IBTR) after partial breast resection and contralateral breast tumor recurrence (CBTR) have been shown to occur relatively frequently in patients with ductal carcinoma in situ (DCIS). However, there is only limited data from Japanese institutes to support this. METHODS: Of 301 consecutive DCIS patients, 179 patients underwent a mastectomy, and the other 122 underwent partial resection in the National Cancer Center Hospital, Tokyo, with a median follow-up period of 2,106 days. We reviewed clinicopathological parameters including age, menopausal status, body mass index, family history (FH) of breast cancer, tumor size, histological subtype, nuclear grade (NG), hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) status, treatment, and the surgical margin status of partially resected specimens. The risk associated with each of these parameters for IBTR in 122 patients who underwent partial resections, and for CBTR in a total of 301 patients were calculated using Cox proportional hazard general linear models. RESULTS: Of the 122 patients who underwent partial breast resection, IBTR occurred in 7 (5.7 %). The risk of IBTR was higher or tended to be higher in younger patients or those with lower NG tumors, but did not change significantly with respect to margin status or irradiation. Amongst the entire cohort of 301 patients, CBTR occurred in 18 cases (6.0 %). CBTR occurred significantly more frequently in patients with a FH of breast cancer and with HR+/HER2− subtype tumors by univariate analyses, and tumor subtype was an independent risk factor for CBTR by multivariate analysis. CONCLUSIONS: The local recurrence rate was low following partial resection of DCIS. Younger age was a risk factor for IBTR, whereas the HR+/HER2− tumor subtype and a FH of breast cancer were risk factors for CBTR. Springer Japan 2015-02-11 2016 /pmc/articles/PMC4839035/ /pubmed/25666939 http://dx.doi.org/10.1007/s12282-015-0595-x Text en © The Author(s) 2015 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Original Article
Tamura, Nobuko
Tsuda, Hitoshi
Yoshida, Masayuki
Hojo, Takashi
Akashi-Tanaka, Sadako
Kinoshita, Takayuki
Sugihara, Kenichi
Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ
title Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ
title_full Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ
title_fullStr Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ
title_full_unstemmed Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ
title_short Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ
title_sort clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839035/
https://www.ncbi.nlm.nih.gov/pubmed/25666939
http://dx.doi.org/10.1007/s12282-015-0595-x
work_keys_str_mv AT tamuranobuko clinicopathologicalpredictivefactorsforipsilateralandcontralateraleventsfollowinginitialsurgerytotreatductalcarcinomainsitu
AT tsudahitoshi clinicopathologicalpredictivefactorsforipsilateralandcontralateraleventsfollowinginitialsurgerytotreatductalcarcinomainsitu
AT yoshidamasayuki clinicopathologicalpredictivefactorsforipsilateralandcontralateraleventsfollowinginitialsurgerytotreatductalcarcinomainsitu
AT hojotakashi clinicopathologicalpredictivefactorsforipsilateralandcontralateraleventsfollowinginitialsurgerytotreatductalcarcinomainsitu
AT akashitanakasadako clinicopathologicalpredictivefactorsforipsilateralandcontralateraleventsfollowinginitialsurgerytotreatductalcarcinomainsitu
AT kinoshitatakayuki clinicopathologicalpredictivefactorsforipsilateralandcontralateraleventsfollowinginitialsurgerytotreatductalcarcinomainsitu
AT sugiharakenichi clinicopathologicalpredictivefactorsforipsilateralandcontralateraleventsfollowinginitialsurgerytotreatductalcarcinomainsitu